← Back to Clinical Trials
Recruiting NCT07075874

NCT07075874 Neutrophil to Lymphocyte Ratio and Postdural Headache

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07075874
Status Recruiting
Phase
Sponsor Istinye University
Condition Preoperative Neutrophil-to-Lymphocyte Ratio (NLR)
Study Type OBSERVATIONAL
Enrollment 821 participants
Start Date 2025-07-12
Primary Completion 2025-07-15

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
PDPH

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 821 participants in total. It began in 2025-07-12 with a primary completion date of 2025-07-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study will aim to investigate whether systemic inflammatory markers-especially the neutrophil-to-lymphocyte ratio (NLR)-obtained from preoperative complete blood counts can predict the development of post-dural puncture headache (PDPH) in obstetric patients undergoing cesarean section under spinal anesthesia.

Eligibility Criteria

Inclusion Criteria: * Women aged 18 years or older * Underwent elective or emergency cesarean section under spinal anesthesia * Had complete preoperative complete blood count (CBC) data available * No known hematological or inflammatory disease * No intraoperative complications recorded * Medical records accessible for postoperative follow-up regarding PDPH symptoms Exclusion Criteria: * Age under 18 * Absence of preoperative complete blood count data * Presence of hematologic malignancy, active infection, autoimmune disease, or immunosuppressive therapy * Platelet count \<150,000/mm³ or INR \>1.5 * Incomplete or missing medical records

Contact & Investigator

Central Contact

ilke dolgun

✉ ilkeser2004@gmail.com

📞 +905555485632

Frequently Asked Questions

Who can join the NCT07075874 clinical trial?

This trial is open to female participants only, aged 18 Years or older, studying Preoperative Neutrophil-to-Lymphocyte Ratio (NLR). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07075874 currently recruiting?

Yes, NCT07075874 is actively recruiting participants. Contact the research team at ilkeser2004@gmail.com for enrollment information.

Where is the NCT07075874 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT07075874 clinical trial?

NCT07075874 is sponsored by Istinye University. The trial plans to enroll 821 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology